07:00 , Mar 19, 2015 |  BC Innovations  |  Distillery Therapeutics

Therapeutics: Dedicator of cytokinesis 5 (DOCK5)

Musculoskeletal disease INDICATION: Osteoporosis In vitro and mouse studies suggest a DOCK5 inhibitor could help treat osteoporosis. DOCK5 has been implicated in osteoclast activity and bone resorption. In vitro, C21 , a small molecule inhibitor...